Metabolic Research
The metabolic peptide category at Portal to Wellness centers on GLP-1 receptor agonists — the most researched class of peptide compounds in modern metabolic science. Glucagon-like peptide-1 (GLP-1) is an incretin hormone released in the gut following food intake; GLP-1 receptor agonists mimic this signal, binding to receptors in the pancreas, hypothalamus, and gastrointestinal tract to modulate appetite, insulin secretion, and gastric emptying.
PTW supplies two primary GLP-1 research compounds:
Semaglutide is a GLP-1 receptor monoagonist. Its extended duration results from a C18 fatty acid modification that enables albumin binding. It is the most widely studied GLP-1 analogue in the published literature.
Tirzepatide is a dual agonist with affinity for both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors.
All PTW metabolic compounds are tested by independent third-party laboratories.
All compounds in this category are supplied for scientific research purposes only and are not intended for human use, diagnosis, or treatment.
Backed by the Research: MOTS-c: The Mitochondrial-Derived Peptide · Visceral Fat and Metabolic Health · Body Recomposition with GLP-1 Peptides — browse the full Research Hub →
Showing 1–12 of 35 results
Don't see the compound you're looking for?
We source compounds on request. Tell us what you need and we'll follow up within 1–2 business days.












